Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yanislava, Ilieva
RPT193-03, NCT05935332: Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma	Terminated	2	38	Europe, US, RoW	RPT193, Placebo	RAPT Therapeutics, Inc.	Asthma	06/24	06/24
TANGO, NCT06029595: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy	Recruiting	2	464	Europe, RoW	Experimental: CHF6001 3200 μg, Placebo Comparator: CHF6001 Placebo	Chiesi Farmaceutici S.p.A.	Uncontrolled Asthma	12/25	12/25